Results 241 to 250 of about 216,339 (397)

Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL‐4, Enhancing Tumor Growth in Hepatocellular Carcinoma

open access: yesCancer Science, EarlyView.
Tumor endothelial cells (TECs) promote the polarization of macrophages to M2 subtype by secreting IL‐4. Downregulation of IL‐4 in TECs suppressed M2 polarization and tumor progression. A high abundance of both TECs and M2 macrophages in HCC specimens is associated with poor prognosis.
Daijiro Matoba   +17 more
wiley   +1 more source

Efficacy and Safety of T‐DXd in HER2+ and Low/Zero Metastatic BCBM: A Retrospective Multicenter Real‐World Study

open access: yesCancer Science, EarlyView.
This real‐world study provides critical evidence supporting the efficacy and safety of T‐DXd in HER2‐positive and HER2‐low breast cancer brain metastases (BCBM), including patients with active/symptomatic disease, leptomeningeal involvement, and poor performance status, thereby addressing unmet needs in clinical practice.
Qingru Zhou   +18 more
wiley   +1 more source

Complete and Early Vitrectomy for Sterile Endophthalmitis After Bevacizumab: A Case Series. [PDF]

open access: yesCureus
Kudasiewicz-Kardaszewska A   +7 more
europepmc   +1 more source

Impact of TP53, KRAS, and APC Mutations on Neoadjuvant Chemotherapy Outcomes in Locally Advanced Rectal Cancer

open access: yesCancer Science, EarlyView.
Genetic profiling of TP53, KRAS, and APC mutations reveals potential as predictors of neoadjuvant chemotherapy efficacy in locally advanced rectal cancer, aiding personalized treatment strategies to improve survival and reduce recurrence risks. ABSTRACT Despite recent advances in neoadjuvant strategies for locally advanced rectal cancer (LARC), optimal
Tomohiro Takeda   +17 more
wiley   +1 more source

Bevacizumab-Associated Enterocutaneous Fistula: A Case Report and Management Review. [PDF]

open access: yesCureus
Wallace ML   +4 more
europepmc   +1 more source

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

open access: yesJournal of the American Medical Association (JAMA), 2017
A. Venook   +22 more
semanticscholar   +1 more source

DNA Methylation in Ovarian and Endometrial Cancers: Predictive and Mechanistic Roles in PARP Inhibitor and ICI Response

open access: yesCancer Science, EarlyView.
Cancer treatment is shifting from an organ‐based framework to one driven by biological phenotypes, and DNA methylation is increasingly recognized as an important factor that governs tumor behavior beyond genetic mutations. In gynecologic cancers, BRCA1 and MLH1 promoter methylation–associated homologous recombination deficiency and mismatch repair ...
Shuhei Kitamura   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy